Trialbee announces strong sales results and a 10 yearlong patient engagement and retention assignment

MALMÖ, SWEDEN and RESEARCH TRIANGLE PARK, NC — September 3, 2019 —

Trialbee announces strong sales results in H1 2019 and the launch of a 10 yearlong assignment for its engagement and retention technology with one of the largest global pharmaceutical companies.

Trialbee, a leading technology company in the development of innovative software to reduce clinical trial recruitment timelines and increase the patient engagement experience, announces the appointment of Richard Thomas as its new member to its Board of Directors.

Trialbee delivered strong YoY sales result for its patient matching and engagement technology and exceeded its H1 2019 sales target by 26%. The sales uptake in H1 2019 is predominately driven by growth within the pharmaceutical customer segment. H1 has also demonstrated an increased interest among some of the leading global Contract Research Organizations, a trend the company believes will continue to develop. Sales in H1 is also indicating that customers are requesting to onboard Trialbee’s technology earlier in the drug development process, which is in line with Trialbee’s sales strategy. The technology platform is gaining more momentum as an embedded solution from clinical trial planning through the patient retention phase.

“We are pleased to note that our solutions are delivering demonstrable recruitment and retention efficiencies for our customers, which has advanced Trialbee to become an embedded healthcare partner with major clients, a key strategic driver for continued double digit growth.” Robert Molander, Chief Commercial Officer at Trialbee, said.

In addition to the strong sales result in H1, Trialbee was also successful in landing its longest engagement and retention assignment with one of the largest pharmaceutical companies. Trialbee’s engagement technology will follow more than 3,000 subjects over a 10-year period to support timely and accurate monitoring of questionnaire completeness. The assignment demonstrates the potential of the technology and future applications, but also the high value it delivers to patients and sponsors in securing reliable long-term study outcomes.

About Trialbee:

Trialbee is a world leading technology provider in patient matching and engagement, empowering patients to participate in clinical trials as a care option. Founded in 2010, Trialbee has continuously innovated patient-centric technology solutions for global clinical trials. Trialbee – Dedicated to patients; driven by science; and powered by data. For more information, visit trialbee.com and contact us at [email protected]

 

Press Contact:
Robert Grimm

+46(0)76-525 82 11
[email protected]

Investor Contact:
Daniel Spasic

Executive Chairman Trialbee
[email protected]

Meet us in Milan during OCT Europe 2019, May 14-15

Meet with Trialbee @OCT Europe 2019

Meet us in Milan, Italy, during OCT Europe 2019, May 14-15!

We will be there to share our latest digital solutions and insights within patient recruitment and patient engagement for patient-centric and accelerated clinical research. Please join us during our session on May 15 “Entering the next dimension in clinical trials with digital recruitment and engagement” and come by our booth #58. Contact George Dorsett to book a meeting for the conference.

Read more about OCT Europe

Trialbee Continues to Contribute to Innovation in Diabetes

Trialbee is pleased to announce a new active partnership with the Diabetes Alliance Sweden. Trialbee´s active participation will hopefully act as a catalyst in the formation of new collaborations, securing that important innovations become available to diabetics in Sweden and globally. 

Trialbee Signs Two Top Ten Pharmaceutical Companies for its Patient-Matching and Engagement Platforms

 Trialbee announces two commercial milestones with two of the top 10 pharma companies. Trialbee has been selected to accelerate the clinical development of new drugs through its patient recruitment platform. The two partnerships also include deployment of Trialbee’s engagement application to ensure patient retention and study procedure compliance.

SCOPE Summit 2019

SCOPE Summit 2019

Meet us in Orlando, Florida during SCOPE Summit 2019, on Feb 18-21 where we will share our latest solutions and insights. Please contact Alicia Foley or Joe Buser to book a meeting.

Read more about SCOPE here.

FierceBiotech: Recruitment specialist Trialbee unveils new patient recruitment and clinical trial platform

Recruitment specialist Trialbee released a new digital patient engagement solution designed to help increase patient retention, protocol compliance and treatment adherence by using customized messaging and support.

“Keeping study patients enrolled and actively engaged in a trial impacts data quality and boosts the statistical power of a study—enabling improved ability to detect differences between treatment groups and speed the process to market,” Hanne Van de Beek, the company’s customer project manager, said in a statement.

Read the full article from FierceBiotech  here.

Trialbee launches Digital Patient Engagement Solutions that enable patient-centric clinical trials

Sponsors, CROs and investigator sites benefit from working together with Trialbee to drive high-quality data and increase statistical power

 MALMÖ, SWEDEN — DECEMBER 04, 2018 — Trialbee, a global provider of best-in-class digital patient recruitment and engagement solutions for clinical research, announces the official release of its digital patient engagement solutions. With Trialbee, sponsors, CROs and investigator sites can increase patient retention, protocol compliance and adherence to treatment plans through customized messaging and support.Trialbee’s digital patient engagement solutions allow sponsors, CROs and sites to improve protocol adherence and reduce data variability, leading to fewer drop-outs and better patient retention. Improving patient retention leads to a more complete set of data points and higher quality data, boosting statistical power.

“Our integrated solutions improve our clients’ opportunities for success with marketing approval and go-to-market timeline,” said Hanne Van de Beek, customer project manager, Trialbee, and trained nurse with many years of experience in clinical drug development. “Keeping study patients enrolled and actively engaged in a trial impacts data quality and boosts the statistical power of a study – enabling improved ability to detect differences between treatment groups and speed the process to market.”

Trialbee puts clinical trials in the hands of patients by integrating studies into their daily lives through a bring-your-own-device (BYOD) application. The app is iOS and Android compatible and includes patient-centric features that can be customized to empower patients with the necessary tools and information, and optimize engagement throughout the entire trial.

The integrated site personnel administration tool and “Participant Manager” simplify site workflow and decrease work burden on research sites. Built-in interactive response technology (IRT) connects patients to sites, driving better adherence to treatment, higher quality data, and improved patient retention.

“We work in close partnership with our clients to put real-time patient data at their fingertips,” said Lollo Eriksson, CEO, Trialbee. “These are long-term relationships in which we customize patient-centric solutions that allow clients to keep patients actively engaged and track and analyze patient flow throughout the entire clinical trial lifecycle.”

About Trialbee

Trialbee empowers patients worldwide with clinical trials as a care option through best-in-class digital patient recruitment and engagement. Founded in 2010 in Sweden, Trialbee has continuously innovated patient-centric solutions for global clinical trials. Trialbee – Dedicated to patients; driven by science; and powered by data. For more information, visit trialbee.com and contact us at [email protected].

Clinical Trials Patient Experience Summit

Join Trialbee in San Francisco, September 12-13, for the Clinical Trials Patient Experience Summit! Set up a meeting with our experienced team members to discuss how to empower patients with clinical trials as a care option through best-in-class digital patient recruitment and retention.

Read more about the Clinical Trials Patient Experience Summit.

7th Annual Patient Recruitment and Retention America Summit

Join Trialbee in Boston, 23-25 October, for the 7th Annual Patient Recruitment and Retention America Summit! Visit booth 6 and discuss how to recruit targeted patients for your clinical trial and how to increase patient retention, compliance, and adherence to treatment plans with our engagement app. In addition, you won’t want to miss Robert Molander, Senior Vice President Marketing, Trialbee, present Clinical Trials as a Care Option at 15:30 on 24 October, where he will discuss making clinical trials more accessible through targeted outreach and smart patient matching.

Read more about the Patient Recruitment and Retention America Summit.

12th Annual Optimizing Clinical Trials Summit

Join Trialbee in London, 2-4 October,  during the 12th Annual Optimizing Clinical Trials Summit! Visit booth 6 to learn how to empower patients with clinical trial as a care option through our best-in-class digital patient recruitment and retention. In addition, you won’t want to miss George Dorsett, Senior Director, Business Development & Customer Solutions, Trialbee, present Clinical Trials as a Care Option at 12:10 on 3 October, where he will discuss making clinical trials more accessible through targeted outreach and smart patient matching.

Read more about the Optimizing Clinical Trials Summit here.

Cookie Preferences

Cloudflare

The Cloudflare cookie is used to identify individual clients behind a shared IP address and apply security settings on a per-client basis.

PHPSESSID,wp-settings-time-1

Google Analytics

Used by Google AdWords to re-engage visitors that are likely to enrol based on the visitor's online behaviour across websites.

_ga,_gid,_gat_UA,_utmc,UULE,CONSENT,1P_JAR,DV

Trialbeehealth

Wordpress built-in cookies to keep user settings after page transitions.

PHPSESSID,wp-settings-time-1

Functional cookies

Allow our websites to remember your user name, language preference, or geographic region. This information is used to provide a personalized experience and to make the website easier to use. If you don’t allow these cookies, then some or all features may not function

variable1

Performance cookies

Collect information about your use of our website, e.g. page visits or error messages. This information is aggregated and anonymized and used to improve our website. If you don’t allow these cookies, we won’t know when you have visited our website and won’t be able to monitor its performance

variable2

Advertising cookies

Allow us to display advertising we think is relevant to you. We build profiles based on your browsing history, which we share with our advertising partners to show you relevant advertisements on other sites. If you don’t allow these cookies you will still receive advertising, but it will be less relevant

variable3

Close your account?

Your account will be closed and all data will be permanently deleted and cannot be recovered. Are you sure?